相似文献
1
Primary prevention of sudden cardiac death.
Heart. 2006 Dec;92(12):1873-8. doi: 10.1136/hrt.2006.087957.
2
Boldly monitoring where few people have monitored before.
Cardiology. 2008;111(4):237-8. doi: 10.1159/000127444. Epub 2008 Apr 23.
3
Sudden cardiac death in the young: the bogeyman.
Cardiol Young. 2015 Mar;25(3):408-23. doi: 10.1017/S1047951114001723. Epub 2014 Sep 17.
4
Preventing sudden death in patients with cardiomyopathies.
Practitioner. 2007 Jun;251(1695):44, 49-51, 53-4 passim.
5
Implantable cardioverter defibrillator criteria for primary and secondary prevention of pediatric sudden cardiac death.
Pacing Clin Electrophysiol. 2009 Jul;32 Suppl 2:S67-70. doi: 10.1111/j.1540-8159.2009.02388.x.
6
Sudden cardiac death in the young.
Crit Care Nurs Q. 2010 Jul-Sep;33(3):219-32. doi: 10.1097/CNQ.0b013e3181e65f98.
7
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.
Eur Heart J. 2006 Sep;27(17):2099-140. doi: 10.1093/eurheartj/ehl199.
8
[Heart risk patient before surgical intervention: how to keep him safe through the operation?].
MMW Fortschr Med. 2011 Nov 10;153(45):18, 20.
9
Arrhythmogenic right ventricular dysplasia: from genetics to treatment.
Anadolu Kardiyol Derg. 2009 Dec;9 Suppl 2:24-31.
10
[Arrhythmias in cardiomyopathies].
Nihon Rinsho. 2002 Jul;60(7):1434-9.
引用本文的文献
1
Validity of MENARI plus (self-pulse assessment and clinical scoring) mobile apps for detecting atrial fibrillation in high-risk population.
J Arrhythm. 2023 May 14;39(4):507-514. doi: 10.1002/joa3.12863. eCollection 2023 Aug.
2
Impact of de novo tachyarrhythmias in patients with prior acute coronary syndrome.
Medicine (Baltimore). 2022 Jul 15;101(28):e29685. doi: 10.1097/MD.0000000000029685.
3
Cardiac MRI and CT features of inheritable and congenital conditions associated with sudden cardiac death.
Eur Radiol. 2009 Feb;19(2):259-70. doi: 10.1007/s00330-008-1169-5. Epub 2008 Sep 16.
本文引用的文献
1
Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD?
Herz. 2005 Mar;30(2):91-101. doi: 10.1007/s00059-005-2677-6.
2
Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association.
Circulation. 2005 Feb 8;111(5):659-70. doi: 10.1161/01.CIR.0000152479.54298.51. Epub 2005 Jan 17.
3
Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials.
JAMA. 2004 Dec 15;292(23):2874-9. doi: 10.1001/jama.292.23.2874.
4
Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction: a pooled analysis of 10 primary prevention trials.
J Am Coll Cardiol. 2004 Dec 7;44(11):2166-72. doi: 10.1016/j.jacc.2004.08.054.
5
Oral erythromycin and the risk of sudden death from cardiac causes.
N Engl J Med. 2004 Sep 9;351(11):1089-96. doi: 10.1056/NEJMoa040582.
6
Hypertrophic cardiomyopathy.
Lancet. 2004 Jun 5;363(9424):1881-91. doi: 10.1016/S0140-6736(04)16358-7.
7
Effects of omega-3 fatty acids on cardiovascular disease.
Evid Rep Technol Assess (Summ). 2004 Mar(94):1-8.
8
Short QT Syndrome: a familial cause of sudden death.
Circulation. 2003 Aug 26;108(8):965-70. doi: 10.1161/01.CIR.0000085071.28695.C4. Epub 2003 Aug 18.
9
Risk stratification in the long-QT syndrome.
N Engl J Med. 2003 May 8;348(19):1866-74. doi: 10.1056/NEJMoa022147.
10
Update of the guidelines on sudden cardiac death of the European Society of Cardiology.
Eur Heart J. 2003 Jan;24(1):13-5. doi: 10.1016/s0195-0668x(02)00809-6.
Zotero 插件